Replies to post #17234 on Viropro, Inc. (VPRO)

[Penny Stocks 2.0]

Viropro estimates the combined, aggregate realizable value of its biosimilars portfolio to be in the range of $33 million to $42 million, depending upon market dynamics of the individual products.